C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 123 filers reported holding C4 THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,888 | -32.4% | 2,628 | 0.0% | 0.00% | – |
Q2 2023 | $7,227 | -12.4% | 2,628 | 0.0% | 0.00% | – |
Q1 2023 | $8,252 | -46.8% | 2,628 | 0.0% | 0.00% | – |
Q4 2022 | $15,505 | -32.6% | 2,628 | 0.0% | 0.00% | – |
Q3 2022 | $23,000 | +15.0% | 2,628 | 0.0% | 0.00% | – |
Q2 2022 | $20,000 | -94.3% | 2,628 | -81.9% | 0.00% | -100.0% |
Q1 2022 | $353,000 | +70.5% | 14,540 | +126.5% | 0.00% | – |
Q4 2021 | $207,000 | -60.3% | 6,420 | -45.0% | 0.00% | -100.0% |
Q3 2021 | $522,000 | – | 11,679 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14,402,000 | 1.72% |
Soleus Capital Management, L.P. | 1,441,513 | $12,642,000 | 1.72% |
Nextech Invest Ltd. | 375,857 | $3,296,000 | 1.06% |
RTW INVESTMENTS, LP | 2,819,472 | $24,727,000 | 0.57% |
ArrowMark Colorado Holdings LLC | 5,091,975 | $44,657,000 | 0.55% |
WASATCH ADVISORS LP | 5,934,476 | $52,045,000 | 0.36% |
HARBOR CAPITAL ADVISORS, INC. | 25,470 | $223,000 | 0.20% |
Perceptive Advisors | 766,231 | $6,720,000 | 0.20% |
DRIEHAUS CAPITAL MANAGEMENT LLC | 606,721 | $5,321,000 | 0.08% |
Virtus ETF Advisers LLC | 19,305 | $169,000 | 0.07% |